logo
Select company
Select metric
15.1%Cash to Assets Ratio
VS
Market
68
Sector
35
Industry
58
History
-
$ 23.4Close
$ 14.65 - $ 34.67 52-Week Range
Ticker Information

Ticker

CSTL

Company Name

CASTLE BIOSCIENCES INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

CASTLE BIOSCIENCES INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CSTL - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 544.73M$ 82.23M15.1%
3/31/2025$ 501.71M$ 89.69M17.88%
12/31/2024$ 531.24M$ 119.71M22.53%
9/30/2024$ 514.57M$ 94.96M18.45%
6/30/2024$ 487.31M$ 85.57M17.56%
3/31/2024$ 458.51M$ 82.95M18.09%
12/31/2023$ 453.34M$ 98.84M21.8%
9/30/2023$ 436.02M$ 91.22M20.92%
6/30/2023$ 425.4M$ 95.87M22.54%
3/31/2023$ 426.89M$ 114.82M26.9%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CASTLE BIOSCIENCES INC's latest trailing twelve months (TTM) Cash to Assets stands at 87%.
  • Over the past 5 years, CASTLE BIOSCIENCES INC's average Cash to Assets has been 45.03%.
  • The median Cash to Assets for CASTLE BIOSCIENCES INC during this period was 27.19%
  • CASTLE BIOSCIENCES INC reached its highest Cash to Assets over the past 5 years at 93.29%.
  • The lowest Cash to Assets recorded by CASTLE BIOSCIENCES INC in the same timeframe 15.1%

CASTLE BIOSCIENCES INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
FLGT : FULGENT GENETICS INC 7.32%CDNA : CAREDX INC 15.48%LAB : STANDARD BIOTOOLS INC 28.48%SNDA : SONIDA SENIOR LIVING INC 3.97%ARVN : ARVINAS INC 12.64%ANGO : ANGIODYNAMICS INC 14.59%RIGL : RIGEL PHARMACEUTICALS INC 25.83%PSNL : PERSONALIS INC 20.63%ESPR : ESPERION THERAPEUTICS INC 24.8%TOI : ONCOLOGY INSTITUTE INC 18.96%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CASTLE BIOSCIENCES INC is calculated as follows: CashnEq [ $ 183.05M ] / Assets [ $ 210.39M ]
(=) Cash to Assets [ 87% ]

CSTL - Cash to Assets Ratio, Last 5 years

15.1%

Minimum

Jun 30, 2025

93.29%

Maximum

Dec 31, 2020

45.03%

Average

27.19%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.83% with a standard deviation of 9.61%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.89%
average9.83%
median6.45%
std9.61%